Profile
Mark J.
Fitzpatrick currently works at Versantis AG, as Chief Executive Officer & Director from 2021 and Allena Pharmaceuticals, Inc., as Independent Director from 2021.
Mr. Fitzpatrick also formerly worked at Repligen Corp., as Principal, Diacrin, Inc. (Delaware), as Chief Financial Officer & Vice President from 1991 to 1998, Dynogen Pharmaceuticals, Inc., as Chief Financial Officer from 1998 to 2009, Proteon Therapeutics, Inc., as Chief Financial Officer & Vice President from 2007 to 2011, Aegerion Pharmaceuticals, Inc., as Chief Financial Officer from 2011 to 2015, Chiasma, Inc., as President & Chief Financial Officer from 2019 to 2021, RenaMed Biologics, Inc., as Chief Financial Officer, WorldStreet Corp., as Chief Financial Officer & Senior Vice President from 1998 to 2002, and Arthur Andersen LLP, as Senior Auditor.
Mr. Fitzpatrick received his undergraduate degree in 1984 from Boston College.
Mark J. Fitzpatrick active positions
| Companies | Position | Start |
|---|---|---|
| ALLENA PHARMACEUTICALS, INC. | Director/Board Member | 05/04/2021 |
Versantis AG
Versantis AG BiotechnologyHealth Technology Develops liver disease therapeutics and diagnostics services | Chief Executive Officer | 30/11/2021 |
Former positions of Mark J. Fitzpatrick
| Companies | Position | End |
|---|---|---|
| CHIASMA, INC. | Chief Executive Officer | 16/06/2019 |
| AEGERION PHARMACEUTICALS, INC. | Director of Finance/CFO | 31/05/2015 |
| PROTARA THERAPEUTICS, INC. | Director of Finance/CFO | 30/04/2011 |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Director of Finance/CFO | 12/11/2009 |
RenaMed Biologics, Inc.
RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services Provided clinical cellular therapy | Director of Finance/CFO | - |
Training of Mark J. Fitzpatrick
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Repligen Corp.
Repligen Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures biologic drugs | Health Technology |
Diacrin, Inc. (Delaware)
Diacrin, Inc. (Delaware) Medical SpecialtiesHealth Technology Develops human cell transplant therapeutic products | Health Technology |
Dynogen Pharmaceuticals, Inc.
Dynogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Proteon Therapeutics, Inc.
Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
Aegerion Pharmaceuticals, Inc.
Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Chiasma, Inc.
Chiasma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops treatments for rare and serious chronic disease | Health Technology |
RenaMed Biologics, Inc.
RenaMed Biologics, Inc. Medical/Nursing ServicesHealth Services Provided clinical cellular therapy | Health Services |
WorldStreet Corp.
WorldStreet Corp. Packaged SoftwareTechnology Services Develops enterprise software applications | Technology Services |
Arthur Andersen LLP
Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Boston College
Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allena Pharmaceuticals, Inc.
Allena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and retails drugs through online | Health Technology |
Versantis AG
Versantis AG BiotechnologyHealth Technology Develops liver disease therapeutics and diagnostics services | Health Technology |
- Stock Market
- Insiders
- Mark J. Fitzpatrick
















